VMI:NYSEValmont Industries, Inc. Analysis
Data as of 2026-07-21 - not real-time
$525.88
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Valmont’s stock is trading at $525.88, just above the identified support level around $521 and well below the 20‑day SMA of roughly $555, indicating a short‑term downside bias. The 50‑day SMA also sits higher than the market price, reinforcing the near‑term pressure. Technical momentum is bearish, with the MACD line deep in negative territory and a histogram that widens the gap to the signal line. Conversely, the RSI hovers near 41, suggesting the stock is not yet oversold. Trading volume has been on a decreasing trend, which can exacerbate price moves on limited liquidity. A discounted cash‑flow model values the company at roughly $124, implying the market is pricing in a substantial premium.
Fundamentally, VMI delivered 6.2% revenue growth year‑over‑year and maintains a healthy operating margin above 15%. Return on equity stands near 22%, underscoring efficient capital use. Free cash flow remains positive and the dividend payout ratio is a modest 15% making the current 0.55% yield sustainable. The firm’s exposure to infrastructure, irrigation and solar‑tracker markets positions it to benefit from long‑term secular demand. However, a price‑to‑book multiple above six and a beta of 1.2 signal higher valuation and market sensitivity. Given the blend of overvaluation, solid fundamentals and sector tailwinds, the stock warrants a cautious stance with upside potential if the price corrects toward fair value.
Fundamentally, VMI delivered 6.2% revenue growth year‑over‑year and maintains a healthy operating margin above 15%. Return on equity stands near 22%, underscoring efficient capital use. Free cash flow remains positive and the dividend payout ratio is a modest 15% making the current 0.55% yield sustainable. The firm’s exposure to infrastructure, irrigation and solar‑tracker markets positions it to benefit from long‑term secular demand. However, a price‑to‑book multiple above six and a beta of 1.2 signal higher valuation and market sensitivity. Given the blend of overvaluation, solid fundamentals and sector tailwinds, the stock warrants a cautious stance with upside potential if the price corrects toward fair value.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD histogram
- Price hovering just above support
- Market price far above DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Steady revenue growth and strong ROE
- Low dividend payout ratio
- Valuation still elevated but improving
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Secular demand in infrastructure and renewable‑energy trackers
- Sustainable dividend and solid cash flow
- Potential price correction toward fair value
Key Metrics & Analysis
Financial Health
Revenue Growth6.20%
Profit Margin8.91%
P/E Ratio29.2
ROE22.19%
ROA10.08%
Debt/Equity54.96
P/B Ratio6.1
Op. Cash Flow$494.8M
Free Cash Flow$187.2M
Industry P/E30.6
Technical Analysis
TrendBullish
RSI41.0
Support$521.59
Resistance$585.71
MA 20$554.70
MA 50$537.56
MA 200$454.68
MACDBearish
VolumeDecreasing
Fear & Greed Index89.46
Valuation
Fair Value$124.46
Target Price$619.50
Upside/Downside17.80%
GradeOvervalued
TypeBlend
Dividend Yield0.55%
Risk Assessment
Beta1.24
Volatility33.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.